ORIGINAL RESEARCH
Accepted on 08 Apr 2025
Dalpiciclib Plus Aromatase Inhibitor Versus Neoadjuvant Chemotherapy for ER-Positive, HER2-negative Breast Cancer
doi 10.3389/fonc.2025.1566146
- 100 views
- Frontiers in Oncology
- Breast Cancer
- Research Topics
- Novel Approaches to Overcome Drug Resistance in Breast Cancer
Novel Approaches to Overcome Drug Resistance in Breast Cancer
417
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.